Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma - Journal of Hepatology
Frontiers | “Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway | Oncology